Lobbying Filing Details

Total Spending

$1,070,000

Activities

5

Lobbyists

4

Gov't Entities

40

Filing Information
Filing UUID:
8350c15f-869a-4db0-b1b8-3e55ed0d1693
Type:
Q1 - 1st Quarter - Report
Period:
2019 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 22, 2019 at 8:30 PM
Income:
$0
Expenses:
$1,070,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Elizabeth Hall
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Consumer Issues/Safety/Products

Telephone Consumer Protection Act

Lobbyists (3)
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 3 more
Activity 2
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
State Health Care Premium Reduction Act (H.R. 1425), Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act (H.R. 1386), and State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385)
Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2019 (S. 340 and H.R. 965)
Mental health and substance use (42 CFR Part 2)
Surprise Medical Billing
Telehealth
Price of prescription drugs
Opioid addiction issues
Prior authorization
Hospital Consolidation (The Hospital Competition Act of 2018, H.R. 7084)
Social Determinants of Health (SDOH)
Privacy and Healthcare Cybersecurity
Health information exchange and interoperability

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 3 more
Activity 3
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
State Health Care Premium Reduction Act (H.R. 1425), Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act (H.R. 1386), and State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385)
Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2019 (S. 340 and H.R. 965)
Mental health and substance use (42 CFR Part 2)
Surprise Medical Billing
Telehealth
Price of prescription drugs
Opioid addiction issues
Prior authorization
Hospital Consolidation (The Hospital Competition Act of 2018, H.R. 7084)
Social Determinants of Health (SDOH)
Privacy and Healthcare Cybersecurity
Health information exchange and interoperability

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 3 more
Activity 4
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, reauthorization of special need plans, star ratings, normalization factors, stars contract consolidation)
Medicare expansion
Mental health and substance use (42 CFR Part 2)
Medicaid managed care
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Removal of safe harbor protections for rebates involving prescription drugs and the creation of new safe harbor protection for certain point-of-sale reductions on price on prescription drugs and certain Pharmacy Benefit Manager (PBM) service fees
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicaid non-emergency medical transportation
ACE Kids Act of 2019 and the Medicaid Services Investment and Accountability Act of 2019 (S. 317, H.R. 1226, and H.R. 1839)
Medicare Advantage Pilot Program in TRICARE

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 3 more
Activity 5
Taxation/Internal Revenue Code

To extend the moratorium and/or repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act
Health Insurance Tax Relief Act of 2019 (H.R. 1398)
Jobs and Premium Protection Act (S. 80)
Health Insurance Tax Relief Act of 2019 (S.172)
The Bipartisan Budget Act of 2018 (H.R. 1892)
Tax exclusion for employer-sponsored health insurance

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 3 more

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.